WPRIM Management System> DCMS> Journal of the Korean Cancer Association> 1992> 24> 1

Volume: 24 Issue: 1

1. A case of malignant lymphoma developed after gastric pseudolymphoma resection. Page:187—193
2. Total necrosis of small cell lung carcinoma after combination chemotherapy and radiotherapy: one case report-. Page:180—186
3. A case report of extraocular sebaceous gland carcinoma with lung metastasis. Page:174—179
4. Cholangiocarcinoma associated with hepatolithiasis. Page:168—173
5. Prognosis of metastatic renal cell carcinoma. Page:160—167
6. Smooth muscle tumors of digestive tract: a clinicopathologic study of 40 cases-. Page:149—159
7. A clinical study of 5-year survival rate of stomach cancer according to postoperative anticancer chemotherapy. Page:140—148
8. A clinicopathologic review of the early gastric adenocarcinoma (231 cases). Page:130—139
9. Conservative surgery and radiation therapy in the treatment of stage I and II breast cancer. Page:125—129
10. Influence of tumor size on chemosensitivity of FSa II in combination of cyclophosphamide and radiation. Page:109—124
11. Treatment of intermediate-grade non-Hodgkin's lymphoma with CAMP-MOB combination chemotherapy. Page:102—108
12. Malignant lymphomas in Korea. Page:92—101
13. Relationship of estrogen receptor status to survival in breast cancer. Page:82—91
14. DNA ploidy, S-phase activity and c-erbB-2 oncogene protein expression in breast cancer and its relationship to prognosis. Page:73—81
15. Changes in the distribution and function of lymphocytes in peripheral blood of cancer patients undergoing radiotherapy. Page:64—72
16. Evaluation immunocompetence in the patients with the brain tumor. Page:56—63
17. Intrapleural instillation of OK-432 for malignant pleural effusion. Page:47—55
18. The antitumor effect of various cytokines on human neuroblastoma cell lines SK-N-SH, IMR-32, and SK-N-MC. Page:35—46
19. Effect of poluadenylic. polyuridylic acid on the activity of antitumor effector cells from patients with adenocarcinoma of stomach. Page:19—34
20. Antitumor components of the cultured mycelia of calvatia craniformis. Page:1—18